Evidence map›Paper›PMID 36380763›Full record

ArticleResearch square2022

Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals.

Jennifer Connors, David Joyner, Nathan Mege, Gina Cusimano, Matthew Bell, Jennifer Marcy, Bhavani Taramangalam, Paulo Lin, Ying Tam, Paulo Lin and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Jennifer ConnorsDrexel University.
David JoynerDrexel University.
Nathan MegeTower Health.
Gina CusimanoDrexel University.
Matthew BellDrexel University.ORCID 0000-0001-7246-4021
Jennifer MarcyDrexel University.
Bhavani TaramangalamDrexel University.
Paulo LinAcuitas Therapeutics.
Ying TamAcuitas Therapeutics.
Paulo LinAcuitas Therapeutics.
Drew WeissmanUniversity of Pennsylvania.
Michele KutzlerDrexel University.
Mohamad-Gabriel AlamehUniversity of Pennsylvania.
Elias HaddadDrexel University.ORCID 0000-0001-6924-4300
Drexel University · USCalifornia University of Pennsylvania · USAcuitas Therapeutics (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the overwhelming success of mRNA-based vaccine in protecting against SARS-CoV-2 infection and reducing disease severity and hospitalization, little is known about the role lipid nanoparticles (LNP) play in initiating immune response. In this report we studied the adjuvantive impact of empty LNP with no mRNA cargo (eLNP) on anti-viral pathways and immune function of cells from young and aged individuals. We found that eLNP induced maturation of monocyte derived dendritic cells by measuring the expression of CD40, CD80, HLA-DR and production of cytokines including IFN-α,IL-6, IFN-γ, IL-12, and IL-21. Flow cytometry analysis of specific dendritic cell subsets showed that eLNP can induce CD40 expression and cytokine production in cDC1, cDC2 and monocytes. Empty LNP (eLNP) effects on dendritic cells and monocytes coincided with induction pIRF7 and pTBK1, which are both important in mitigating innate immune signaling. Interestingly our data show that in response to eLNP stimulus at 6 and 24 hrs, aged individuals have decreased CD40 expression and reduced IFN- γ output compared to young adults. Furthermore, we show that cDC1, cDC2, and CD14

Identifiers

PMID36380763
PMCPMC9665340
OpenAlexW4309667309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.